Thermo Fisher Scientific Inc. Financials: Revenue, Profit, Balance Sheet & Cash Flow

Thermo Fisher Scientific Inc. Score & Ratio Trend

Date	Score	P/E	P/B	D/E	Price
Oct 2026	17,676	35.2	4.60	0.81	62,983.17
Oct 2026	17,676	35.2	4.60	0.81	62,976.70
Oct 2026	17,676	35.2	4.60	0.81	62,976.70
Oct 2026	17,437	36.4	4.75	0.81	65,088.75
Oct 2026	17,980	35.3	4.61	0.81	63,306.17
Oct 2026	17,979	36.4	4.61	0.81	63,306.17
Oct 2026	17,921	35.6	4.65	0.81	63,912.50
Oct 2026	18,030	35.1	4.58	0.81	62,939.42
Oct 2026	17,715	35.4	4.62	0.81	63,667.65
Oct 2026	17,668	35.6	4.65	0.81	63,403.21
Oct 2026	18,062	35.7	4.65	0.81	63,143.75
Oct 2026	17,953	36.2	4.72	0.81	63,918.65
Oct 2026	17,755	36.9	4.89	0.81	66,139.41
Oct 2026	17,840	37.1	4.84	0.81	65,353.32
Oct 2026	17,954	36.6	4.77	0.81	64,416.36
Oct 2026	17,868	37.0	4.82	0.81	65,173.94
Oct 2026	17,810	37.4	4.87	0.81	65,641.92
Oct 2026	18,049	35.7	4.75	0.75	63,859.17
Oct 2026	18,078	35.5	4.73	0.75	63,866.13

Line Item	Jun 2026	Mar 2026	Dec 2025	Sep 2025
Revenue	11,994,000,000.0	11,005,000,000.0	12,215,000,000.0	11,122,000,000.0
Net Profit	1,736,000,000.0	1,651,000,000.0	1,964,000,000.0	1,616,000,000.0
EPS	4.7	4.4	5.2	4.3

Line Item	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Revenue	44,557,000,000.0	42,879,000,000.0	42,857,000,000.0	44,915,000,000.0
Net Profit	6,704,000,000.0	6,335,000,000.0	5,995,000,000.0	6,950,000,000.0
EPS	17.8	16.6	15.5	17.8

Line Item	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Total Assets	110,343,000,000.0	97,321,000,000.0	98,726,000,000.0	97,154,000,000.0	—
Total Liabilities	56,807,000,000.0	47,649,000,000.0	51,884,000,000.0	53,006,000,000.0	—
Total Equity	53,407,000,000.0	49,585,000,000.0	46,735,000,000.0	43,978,000,000.0	—

Thermo Fisher Scientific Inc. owed $0.53 for every $1 it owned in Jun 2026, down from $0.55 in Dec 2022.

Period	Jun 2026	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Owes vs Owns	0.53×	0.51×	0.49×	0.53×	0.55×

Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.

What it owns — Dec 2025

Cash & short-term investments 9.2%Receivables 9.6%Inventory 4.9%Fixed assets (tangible) 9.6%Intangible assets 59.1%Other assets 7.7%

How it's funded — Dec 2025

Short-term debt 3.2%Long-term debt 32.5%Payables 3.3%Other liabilities 12.5%Shareholders' equity 48.5%

Line Item	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Assets
Cash & short-term investments	10,105.0	5,570.0	8,080.0	8,524.0
Receivables	10,566.0	9,626.0	9,664.0	9,427.0
Inventory	5,425.0	4,978.0	5,088.0	5,634.0
Fixed assets (tangible)	10,565.0	9,306.0	9,448.0	9,280.0
Intangible assets	65,200.0	61,386.0	60,690.0	58,638.0
Long-term investments	0.0	0.0	0.0	0.0
Other assets	8,482.0	6,455.0	5,756.0	5,651.0
Liabilities & equity
Short-term debt	3,533.0	2,214.0	3,609.0	5,579.0
Long-term debt	35,852.0	29,061.0	31,308.0	28,909.0
Payables	3,622.0	3,079.0	2,872.0	3,381.0
Other liabilities	13,800.0	13,295.0	14,095.0	15,137.0
Shareholders' equity	53,536.0	49,672.0	46,842.0	44,148.0
Net tangible assets	-11,793.0	-11,801.0	-13,955.0	-14,660.0

Line Item	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Operating Activities	7,818,000,000.0	8,667,000,000.0	8,406,000,000.0	9,154,000,000.0	—
Investing Activities	-4,047,000,000.0	-5,841,000,000.0	-5,142,000,000.0	-2,159,000,000.0	—
Financing Activities	1,801,000,000.0	-6,792,000,000.0	-3,622,000,000.0	-2,810,000,000.0	—